Search

By Industry Solutions (2)
By Phase (1)
By Molecule Type (1)
By Therapeutic Area (3)
Covance Events (9)
Geography (3)
Keywords (10)

Filters

Showing results 1329 - 1344 of 91813 for .

Showing results 1329 - 1344 of 91813 for .

Xcellerate® Informatics Demo Video
See how stronger insights and greater oversight through the combined capabilities of the Xcellerate Informatics Platform can optimize your clinical trial outcomes.
Early Phase Development Solutions
With Covance Early Phase Development Solutions, you get the benefit of one consistent and dedicated molecule solution team to advance your program from nonclinical, through First-in-Human ready, Phase II ready, Proof of Concept and on through to final clinical development.
In about 60 seconds: Meet Lori Ross from Covance
Covance clients benefit from the accessibility of our scientific staff. The "In about 60 seconds" video biography series allows you to pull up a virtual chair and put a face with a name. Meet just a few of the good people who come together to bring you the knowledge and service you have come to expect from Covance.
Turning Biorepositories into Translational Science Treasure Troves
The Value of Uniquely Complete Data Sets: As clinical trials incorporate wider patient populations around the globe and the number of biomarker assays available increases, your specimen biorepositories represent an increasingly valuable resource for translational science. Learn how to get more value from your biorepository specimens by transcending data silos and gaining pan-pipeline insights to help you bring fresh approaches to your research.
In about 60 seconds: Meet Virginia Deibel from Covance
Covance clients benefit from the accessibility of our scientific staff. The "In about 60 seconds" video biography series allows you to pull up a virtual chair and put a face with a name. Meet just a few of the good people who come together to bring you the knowledge and service you have come to expect from Covance.
Biopharmaceutical Characterization by LC-MS
Quanitifcation of N-Glycan core afucosylation is a novel approach linking biosimilar structural differences to variation in functional activity. View the webinar to learn more about this solution and its significance to risk-mitigated analytical control strategy.
Xcellerate® Trial Management Demo Video-Chinese Subtitles
See how you can unite data systems to view, track and report performance metrics across countries, studies and sites in near real time with Xcellerate® Trial Management.
Understanding the US Market Access Landscape for Biosimilars
Gain a better understand of CMS policies and their implications as well as insight into commercial payers' management of biosimilars.
The Role of Biomarkers and Companion / Complementary Diagnostics in Immuno-Oncology Trials
Covance Chief Scientific Officer Steven M. Anderson, PhD during our recent webinar where he discussed the spectrum of immunotherapy development considerations and their implications for drug developers. This webinar covers a variety of topics, including: Biomarker approaches, Cell-based assays, Tissue based biomarker assays, Genomic biomarkers,Engaging a CRO or lab partner
Xcellerate® Monitoring Demo Video-Japanese Subtitles
See how you can mitigate risks by monitoring your medical, statistical and operational data to keep your trial on track with Xcellerate® Monitoring.
Analytical Methods for Bioanalysis
List of validated, nonproprietary LC-MS methods developed for more than 330 compounds according to FDA Crystal City and current regulatory guidelines.
Immunological Mechanisms of Vaccine-elicited Protection: Licensed Vaccines
In this presentation, we will cover known or suspected mechanisms that mediate protection elicited by very different licensed vaccines: MMRV (anti-Measles, -Mumps, -Rubella and -Varicella), Pertussis (anti-whooping cough), and the recently introduced anti-serogroup B meningococcal vaccines. We will also discuss the contribution of antibodies and the complex role of the human complement system along with key areas where significant challenges can be turned into scientific, technical and...
Xcellerate® Monitoring: Measuring success, challenges, results & solutions
Clinical trials have become more complex, driving a need for more advanced and efficient ways to monitor patient safety and ensure quality test results. Yet there is no single definition of "success" to measure improved trial performance. Join Chris McConachy, Senior Manager, Monitoring & Data Flow Optimization, as he discusses challenges and solutions to gather key success metrics in monitoring in this webinar.
Rare Diseases and Orphan Drugs Solutions: An Integrated Approach to Rare Disease
Learn more about a range of individual approaches that can be integrated to accelerate progress of complex Rare Disease studies across the world.
Webinar: Getting the Best from a Radiosynthesis CRO
23-minute videotape presentation by George Ellames, head of isotope chemistry for Covance in Alnwick, UK discussing how clients get the best from a radiosynthesis CRO.
Determining Target Occupancy Using LC-MS
Advantages and Applications to a Preclinical Drug Discovery Paradigm